A Nation’s Cry & A Moment for Greater Diversity in Clinical Trials

Since 2020 began, the U.S. Food & Drug Administration (FDA) has approved at least twenty new drugs for use by American consumers, but over 90% of those drugs were tested on a subject population that lacked sufficient race and ethnic diversity to determine if the drug would be safe and effective for everyone.  With aContinue reading “A Nation’s Cry & A Moment for Greater Diversity in Clinical Trials”